GovChime
Notice ID: cb1140c96dc941cbb2c5f0769d83d9d1Special Notice

FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

Archived on September 30, 2025. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
11:59 PM UTC−05:00
Posted
February 26, 2025
Notice type
Special Notice
NAICS
541714: Research and Development in Biotechnology (except Nanobiotechnology)
Agency
Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION

Notice details

Office
FDA Office of Acquisitions and Grants Services
Place of performance
Silver Spring, 20993
PSC
AJ11: GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Last updated
Dec 5, 2025

Identifiers

Solicitation number
FDABAA-25-00123
Notice ID
cb1140c96dc941cbb2c5f0769d83d9d1

Description

Amendment 05 - The BAA Notice has been updated to version 6 with various changes throughout. Amendment 04 - The BAA Notice has been updated to version 5 with various changes throughout. Table 1 and attachment 5 have also been updated and included seperately. The response date has been changed to March 04th at 1159 PM EST. Amendment 03 - The BAA Notice has been updated to version 4 with various changes throughout, Table 1 and attachments 4 and 5 have also been updated and included seperately. Amendment 02 - The BAA Notice has been updated to version 3 with various changes throughout. Amendment 01 - The BAA Notice has been updated to version 2 with various changes throughout, and table 1 has been updated and included seperately. In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement. FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation. Join us to learn more about the FY 2025 BAA, and how to apply. Save the date for the 2024 FDA Broad Agency Announcement (BAA) Day! November 14th, 2024. BAA Day for FY25 2024 will be hosted on November 14th, 2024, as a virtual only event and will provide an opportunity to learn more about the application process and FDAs priorities for regulatory research. https://www.fda.gov/science-research/advancing-regulatory-science/2024-fda-broad-agency-announcement-day-11142024

Full description on SAM.gov

Award Overview

Contacts

Contracting Officer

Primary Contact

Documents

No documents available.

Lifecycle

Solicitation:FDABAA-25-00123
  1. 9×
    Special NoticeCurrentOct 3, 2024

    FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

    Notice cb1140c96dc941cbb2c5f0769d83d9d1 on SAM.gov

Similar Opportunities

Additional Details

Solicitation Number

FDABAA-25-00123

Archive Date

Sep 30, 2025